Coverage

What this covers, and what is still open.

A resource worth trusting is honest about its own edges. This is the map of the territory: the parts of the AI operating system and the biotech lifecycle that are covered, the ones that are started, and the ones still empty and being filled on purpose.

Covered real resources exist. Started one piece, more coming. Planned acknowledged, not yet written.

The AI operating system

The biotech lifecycle

  • Planned Discovery and target identification Open territory. On the roadmap.
  • Planned Preclinical development Open territory. On the roadmap.
  • Planned Translational medicine and biomarkers Open territory. On the roadmap.
  • Started Clinical development and operations Where AI Touches a Clinical-Stage Biotech
  • Started Regulatory affairs and quality The validated-workflow boundary
  • Planned Pharmacovigilance and safety Open territory. On the roadmap.
  • Planned CMC, process development, and manufacturing Open territory. On the roadmap.
  • Planned Medical affairs and commercial Open territory. On the roadmap.
  • Planned Data, software, and AI infrastructure Open territory. On the roadmap.
  • Planned Board and investor oversight Open territory. On the roadmap.

The plan is not to publish thin coverage of everything at once. It is to make a small number of pages impossible to dismiss, each with a diagram, boundary conditions, primary evidence, a tool, and eventually a real case, then extend outward. New functional maps land on the model set by the clinical-stage map. If a function you need is still open, tell me what you are trying to do, and it moves up the list.